Kathleen Rodgers

Professor - Tucson

 

Associate Director, Translational Neuroscience 

UArizona Center for Innovation in Brain Science

Professor, Pharmacology
 

Board Certification

1992-2022 American Board of Toxicology 

Research areas

Cardiovascular pharmacology

Immunopharmacology

Neuroscience and pain 

Toxicology 

Research Overview

My research over the last 30 years has evaluated the ability of angiotensin peptides and small molecule Mas agonists to mitigate injury and regenerate injured tissues and product development. Stimulation of Mas through endogenous peptides, analogues and peptidomimetics has been shown to increase stem cells/progenitors in a number of disease states with a deficit regenerative cells and to reduce oxidative stress and inflammation. By targeting these three fundamental processes, a platform leading to clinical development from laboratory observations has led has been generated.  Current disease targets include vascular dementia, Alzheimer’s Disease and multiple sclerosis.

520-626-4114
Research Interests: 
Cardiology and Cardiovascular Science
Immunobiology
Neuroscience
Pharmacology
Toxicology